News
-
-
PRESS RELEASE
Proof-of-Concept Results Show Jaguar Health's Crofelemer Reduced Total Parenteral Nutrition in Third Intestinal Failure Orphan Disease Patient
Initial proof-of-concept results show crofelemer's efficacy in reducing TPN for intestinal failure patients. Jaguar seeking partnerships for drug development and commercialization -
-
-
PRESS RELEASE
Amaze Surpasses 200 Million Storefront Visits, Solidifying Leadership in Rapidly Expanding Creator Economy
Amaze Software, Inc., a leader in creator-powered commerce, surpasses 200 million storefront visits, fuelled by 13 million global creators. Strategic growth reflects creator monetization trends -
-
-
PRESS RELEASE
Greenlane Bolsters Global Sales Effort with Appointment of Mike Hinson as Executive Vice President of Sales
Greenlane Holdings, Inc. appoints Mike Hinson as Executive Vice President of Sales. Hinson brings 2 decades of experience in sales leadership, revenue optimization, and business development -
-
PRESS RELEASE
Original-Research: Jaguar Health Inc (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates Buy recommendation on Jaguar Health Inc (ISIN: US47010C8055) to USD 40 target price post-positive breast cancer trial subgroup results. Plans for FDA approval through pivotal trial and orphan drug designation
